Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cora N Sternberg

Showing results (101-110 of 357) with videos related to

Pageof 36
Sort By:
Clinical Genitourinary Cancer|September 6, 2024
Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical RationaleCora N Sternberg, Stephen J Freedland, Daniel J George, et al.
Urologic Oncology|December 30, 2008
Optimizing outcomes at every stage of bladder cancer: do we practice it?Harry Herr, Badrinath Konety, John Stein, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
Future directions and targeted therapies in bladder cancerGuru Sonpavde, Benjamin S Jones, Joaquim Bellmunt, et al.
BJU International|April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancerKarim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Drugs|May 21, 2010
Castration-resistant prostate cancer: current and emerging treatment strategiesGiuseppe Di Lorenzo, Carlo Buonerba, Riccardo Autorino, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysisChiara Ciccarese, Roberto Iacovelli, Cora N Sternberg, et al.
Clinical Nuclear Medicine|April 8, 2026
Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone FlareValentina Marulanda-Corzo, Preeti Kakkar, Arman Sharbatdaran, et al.
Oncology|September 18, 2014
An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinomaCora N Sternberg, Ian D Davis, Keith C Deen, et al.
Urology|February 9, 2002
Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experienceVito Pansadoro, Paolo Emiliozzi, Francesco de Paula, et al.
Journal of Psychosomatic Research|July 29, 2008
Differences in depressive thoughts between major depressive disorder, IFN-alpha-induced depression, and depressive disorders among cancer patientsMassimo Pasquini, Azzurra Speca, Simona Mastroeni, et al.
Pageof 36

Showing results (101-110 of 357) with videos related to

Sort By:
Pageof 36
Clinical Genitourinary Cancer|September 6, 2024
Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical RationaleCora N Sternberg, Stephen J Freedland, Daniel J George, et al.
Urologic Oncology|December 30, 2008
Optimizing outcomes at every stage of bladder cancer: do we practice it?Harry Herr, Badrinath Konety, John Stein, et al.
Hematology/Oncology Clinics of North America|April 4, 2015
Future directions and targeted therapies in bladder cancerGuru Sonpavde, Benjamin S Jones, Joaquim Bellmunt, et al.
BJU International|April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancerKarim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Drugs|May 21, 2010
Castration-resistant prostate cancer: current and emerging treatment strategiesGiuseppe Di Lorenzo, Carlo Buonerba, Riccardo Autorino, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysisChiara Ciccarese, Roberto Iacovelli, Cora N Sternberg, et al.
Clinical Nuclear Medicine|April 8, 2026
Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone FlareValentina Marulanda-Corzo, Preeti Kakkar, Arman Sharbatdaran, et al.
Oncology|September 18, 2014
An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinomaCora N Sternberg, Ian D Davis, Keith C Deen, et al.
Urology|February 9, 2002
Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experienceVito Pansadoro, Paolo Emiliozzi, Francesco de Paula, et al.
Journal of Psychosomatic Research|July 29, 2008
Differences in depressive thoughts between major depressive disorder, IFN-alpha-induced depression, and depressive disorders among cancer patientsMassimo Pasquini, Azzurra Speca, Simona Mastroeni, et al.
Pageof 36